Published: Jan. 3, 2018

Proposal due 1/17: 
Dana Foundation David Mahoney Neuroimaging Program

The Research & Innovation Office (RIO) announces a limited submission internal competition for the Dana Foundation's David Mahoney Neuroimaging Program. The program focuses on improving human brain and brain-immune functioning to promote health, and prevent and treat disease. Funds support pilot-testing by investigators, who are early in their research careers, to enable them to pursue promising, high-risk, and innovative ideas that have a direct clinical application. The pilot data are anticipated to help increase competitiveness for seeking larger-scale support from other funders. 

The internal application requirements and link are below. Questions should be sent to

All interested applicants should review the Procedures for Limited Campus Competitions.

Program Summary

The Dana Foundation's David Mahoney Neuroimaging Program, like all other Dana-supported research, is designed to improve human health. Investigations need to be applicable to human brain or brain-immune functioning or malfunctioning. To be considered for funding, submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers.

Previously funded studies under this Program have focused primarily on:

  1. Understanding normal brain functioning, how it is altered by disease or injury, and how it recovers or repairs;
  2. Assessing and improving diagnostic and therapeutic approaches; and
  3. Refining and advancing imaging technologies to address specific clinical questions.

In addition to these three general areas of continued interest, it is becoming increasingly apparent that neurodegenerative diesases, such as Alzheimer's and Parkinson's disease, and mental illnesses such as schizophrenia and depression, start long before they are clinically evident. The Foundation, therefore, encourages studies that seek to understand developmental processes of disease, surrogate measures of early disease existence, and measures of disease progression.


  • CU Boulder Internal Competition Deadline: 11:59pm MST January 17, 2018
  • Dana Foundation Deadline: 3:00pm EST February 5, 2018

Internal Application Requirements

Applications should be in PDF format, using an 11-point font, 0.5 inch margins and numbered pages.

Requirements include:

  • Cover page:
    • Include the project title, PI, contact information
    • Indicate the imaging category (structural/physiological or cellular/molecular, or a combination of both) and specify the imaging technique(s) to be used (such as fMRI, two-photon, etc)
  • 2-page proposal that includes the five sections outlined on the program's request for proposals:
    1. Clearly stated hypothesis
    2. Aims of the project
    3. Research significance
    4. Method
    5. Qualifications of the PI(s)

Access Online Application


Support is focused on faculty researchers who have demonstrated the potential for independent research careers who are at the assistant professor level, or in the first few years of their associate professor appointments.

Post-doctoral fellows are not eligible to apply. Applications from junior investigators that are an extension of the work of a senior mentor, particularly if from the same institution, are discouraged.

Limited Submission Guidelines

CU Boulder may nominate one applicant.

Award Information and Duration

Grant amounts for each study may be up to $200,000 total, payable over three years. Applicants will be informed within eight weeks of the preliminary proposal deadline on whether they are invited to prepare full proposals. The first awards will be announced in September 2018. Subsequent award announcements will be made in December 2018.

Evaluation Criteria

Detailed information about the selection process can be found on the program’s request for proposals.